Aspen Aerogels (ASPN) Misses Q4 EPS by 8c
Aspen Aerogels (NYSE: ASPN) reported Q4 EPS of ($0.25), $0.08 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $27.6 million versus the consensus estimate of $29.08 million.
GUIDANCE:
Aspen Aerogels sees FY2017 EPS of ($0.91)-($0.78). Aspen Aerogels sees FY2017 revenue of $102-112 million.
For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.